-
Obesity continues to raise concerns, in spite of greater public awareness of its associated problems and challenges.
-
A short trial of a synthetic cannabinoid for people with advanced cancer was shown to improve caloric intake, appetite, and sensory perceptions around food, as well as quality of life.
-
A small study of the effects of acute cell phone use on brain glucose metabolism revealed significant increases in areas near the location of a phone's antenna. The findings do not imply that cell phone use causes brain damage, only that the electromagnetic fields from them do cause changes in brain function.
-
Results of the DOMInO (DHA to Optimize Mother and Infant Outcomes) randomized control trial did not support using fish oil (DHA predominant) to prevent maternal postpartum depression or to improve cognitive ability in children at 18 months of age.
-
Dietary fiber intake appears to lower all-cause mortality, including death from cardiovascular, infectious, and respiratory diseases.
-
Compared with manual, automated blood pressure measurements significantly reduced the white coat response in otherwise healthy primary care patients with systolic hypertension while demonstrating a stronger correlation with awake ambulatory blood pressure readings.
-
The Wells rule for identifying patients at high risk for DVT did not perform as well as one developed from an outpatient population.
-
In a two-year study, postmenopausal women randomized to nitroglycerin ointment group had significant increases in areal BMD at the lumbar spine, total hip, and femoral neck and decreased bone resorption.
-
A broad-spectrum, parenteral, cephalosporin with activity against both gram-positive and gram-negative bacteria has been approved by the FDA. Ceftaroline fosamil is the prodrug of ceftaroline and is marketed by Forest Pharmaceuticals as Teflaro™.
-
In animal models, aspirin (asa) has favorable effects on the incidence and/or growth rate of some cancers (CA).
